Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06081244
Title NeoAdj. Therapy Comparing Sacituzumab Govitecan (SG) vs. SG+Pembrolizumab in Low-risk, Triple-neg. EBC (ADAPT-TN-III) (ADAPT-TN-III)
Acronym ADAPT-TN-III
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors West German Study Group
Indications
Therapies
Age Groups: adult | senior
Covered Countries DEU

Facility Status City State Zip Country Details
Kliniken Essen-Mitte, Klinik für Senologie/Interdisziplinäres Brustzentrum RECRUITING Essen NRW 45136 Germany Details
Ev. Krankenhaus Bethesda Brustzentrum Niederrhein RECRUITING Mönchengladbach NRW 41061 Germany Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field